ASTERA LABS INC (ALAB)

US04626A1034 - Common Stock

104.12  +6.7 (+6.88%)

After market: 104.2 +0.08 (+0.08%)

Fundamental Rating

4

ALAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for ALAB as it has an excellent financial health rating, but there are worries on the profitability. ALAB is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

ALAB had negative earnings in the past year.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.67%, ALAB is doing worse than 62.04% of the companies in the same industry.
The Return On Equity of ALAB (-2.95%) is worse than 62.04% of its industry peers.
Industry RankSector Rank
ROA -2.67%
ROE -2.95%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 68.94%, ALAB belongs to the best of the industry, outperforming 90.74% of the companies in the same industry.
ALAB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

9

2. Health

2.1 Basic Checks

ALAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALAB has about the same amout of shares outstanding than it did 1 year ago.
ALAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 99.94 indicates that ALAB is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALAB (99.94) is better than 99.07% of its industry peers.
There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 99.94
ROIC/WACCN/A
WACC14.76%

2.3 Liquidity

ALAB has a Current Ratio of 10.74. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
ALAB has a better Current ratio (10.74) than 98.15% of its industry peers.
A Quick Ratio of 10.46 indicates that ALAB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 10.46, ALAB belongs to the best of the industry, outperforming 98.15% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.74
Quick Ratio 10.46

5

3. Growth

3.1 Past

ALAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.00%, which is quite impressive.
ALAB shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.97%.
EPS 1Y (TTM)55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)44.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 77.08% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 63.36% on average over the next years. This is a very strong growth
EPS Next Y503.34%
EPS Next 2Y187.2%
EPS Next 3Y122.47%
EPS Next 5Y77.08%
Revenue Next Year228.95%
Revenue Next 2Y126.5%
Revenue Next 3Y90.67%
Revenue Next 5Y63.36%

3.3 Evolution

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALAB. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 96.78, the valuation of ALAB can be described as expensive.
62.04% of the companies in the same industry are cheaper than ALAB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.82. ALAB is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 96.78

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALAB's earnings are expected to grow with 122.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y187.2%
EPS Next 3Y122.47%

0

5. Dividend

5.1 Amount

ALAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASTERA LABS INC

NASDAQ:ALAB (11/21/2024, 6:01:28 PM)

After market: 104.2 +0.08 (+0.08%)

104.12

+6.7 (+6.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap16.51B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 96.78
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.67%
ROE -2.95%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 68.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 10.74
Quick Ratio 10.46
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)55%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y503.34%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)44.97%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y